New hep C drugs: GPs concerned over lack of detail

GPs are keen to join a new training program allowing them to prescribe a new generation of hepatitis C superdrugs to be listed on the PBS from 1 March.

But the lack of detailed information for GPs, allied health professionals and even pharmacists is leading to concerns of possible delays and treatment bottlenecks in achieving a mass rollout.

Hepatitis C is one of Australia’s largest public health problems. An estimated 230,000 patients have the disease, 10,000 new cases are reported annually, and it is responsible for up to 700